Cargando…

Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss

While cell therapies hold remarkable promise for replacing injured cells and repairing damaged tissues, cell replacement is not the only means by which these therapies can achieve therapeutic effect. For example, recent publications show that treatment with varieties of adult, multipotent stem cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumgartner, James E., Baumgartner, Linda S., Baumgartner, Michael E., Moore, Ernest J., Messina, Steven A., Seidman, Michael D., Shook, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848325/
https://www.ncbi.nlm.nih.gov/pubmed/33034162
http://dx.doi.org/10.1002/sctm.20-0026
_version_ 1783645110298214400
author Baumgartner, James E.
Baumgartner, Linda S.
Baumgartner, Michael E.
Moore, Ernest J.
Messina, Steven A.
Seidman, Michael D.
Shook, David R.
author_facet Baumgartner, James E.
Baumgartner, Linda S.
Baumgartner, Michael E.
Moore, Ernest J.
Messina, Steven A.
Seidman, Michael D.
Shook, David R.
author_sort Baumgartner, James E.
collection PubMed
description While cell therapies hold remarkable promise for replacing injured cells and repairing damaged tissues, cell replacement is not the only means by which these therapies can achieve therapeutic effect. For example, recent publications show that treatment with varieties of adult, multipotent stem cells can improve outcomes in patients with neurological conditions such as traumatic brain injury and hearing loss without directly replacing damaged or lost cells. As the immune system plays a central role in injury response and tissue repair, we here suggest that multipotent stem cell therapies achieve therapeutic effect by altering the immune response to injury, thereby limiting damage due to inflammation and possibly promoting repair. These findings argue for a broader understanding of the mechanisms by which cell therapies can benefit patients.
format Online
Article
Text
id pubmed-7848325
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78483252021-02-05 Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss Baumgartner, James E. Baumgartner, Linda S. Baumgartner, Michael E. Moore, Ernest J. Messina, Steven A. Seidman, Michael D. Shook, David R. Stem Cells Transl Med Perspectives While cell therapies hold remarkable promise for replacing injured cells and repairing damaged tissues, cell replacement is not the only means by which these therapies can achieve therapeutic effect. For example, recent publications show that treatment with varieties of adult, multipotent stem cells can improve outcomes in patients with neurological conditions such as traumatic brain injury and hearing loss without directly replacing damaged or lost cells. As the immune system plays a central role in injury response and tissue repair, we here suggest that multipotent stem cell therapies achieve therapeutic effect by altering the immune response to injury, thereby limiting damage due to inflammation and possibly promoting repair. These findings argue for a broader understanding of the mechanisms by which cell therapies can benefit patients. John Wiley & Sons, Inc. 2020-10-09 /pmc/articles/PMC7848325/ /pubmed/33034162 http://dx.doi.org/10.1002/sctm.20-0026 Text en © 2020 The Authors. stem cells translational medicine published by Wiley Periodicals LLC on behalf of AlphaMed Press. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Perspectives
Baumgartner, James E.
Baumgartner, Linda S.
Baumgartner, Michael E.
Moore, Ernest J.
Messina, Steven A.
Seidman, Michael D.
Shook, David R.
Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss
title Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss
title_full Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss
title_fullStr Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss
title_full_unstemmed Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss
title_short Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss
title_sort progenitor cell therapy for acquired pediatric nervous system injury: traumatic brain injury and acquired sensorineural hearing loss
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848325/
https://www.ncbi.nlm.nih.gov/pubmed/33034162
http://dx.doi.org/10.1002/sctm.20-0026
work_keys_str_mv AT baumgartnerjamese progenitorcelltherapyforacquiredpediatricnervoussysteminjurytraumaticbraininjuryandacquiredsensorineuralhearingloss
AT baumgartnerlindas progenitorcelltherapyforacquiredpediatricnervoussysteminjurytraumaticbraininjuryandacquiredsensorineuralhearingloss
AT baumgartnermichaele progenitorcelltherapyforacquiredpediatricnervoussysteminjurytraumaticbraininjuryandacquiredsensorineuralhearingloss
AT mooreernestj progenitorcelltherapyforacquiredpediatricnervoussysteminjurytraumaticbraininjuryandacquiredsensorineuralhearingloss
AT messinastevena progenitorcelltherapyforacquiredpediatricnervoussysteminjurytraumaticbraininjuryandacquiredsensorineuralhearingloss
AT seidmanmichaeld progenitorcelltherapyforacquiredpediatricnervoussysteminjurytraumaticbraininjuryandacquiredsensorineuralhearingloss
AT shookdavidr progenitorcelltherapyforacquiredpediatricnervoussysteminjurytraumaticbraininjuryandacquiredsensorineuralhearingloss